Lu, Y., Jin, X., Duan, C., & Chang, F. (2018). Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naïve patients in China. Public Library of Science (PLoS).
Chicago-stil citatLu, Yun, Xiuze Jin, Cheng-A-Xin Duan, och Feng Chang. Cost-effectiveness of Daclatasvir Plus Asunaprevir for Chronic Hepatitis C Genotype 1b Treatment-naïve Patients in China. Public Library of Science (PLoS), 2018.
MLA-referensLu, Yun, Xiuze Jin, Cheng-A-Xin Duan, och Feng Chang. Cost-effectiveness of Daclatasvir Plus Asunaprevir for Chronic Hepatitis C Genotype 1b Treatment-naïve Patients in China. Public Library of Science (PLoS), 2018.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.